Open Accessibility Menu

Clinical Trial Information

Enhancing Fear Extinction via Angiotensin Type 1 Receptor Inhibition: A randomized Controlled Trial in Posttraumatic Stress Disorder

Study Details

The primary objective of this study is to evaluate the efficacy of losartan during 10 weeks of treatment for adults with posttraumatic stress disorder (PTSD).

Primary Sponsor:

US. Department of Defense

Prinicipal Investigator:

Suzan Song

Contact Phone:

(202) 677-6141
Enhancing Fear Extinction via Angiotensin Type 1 Receptor Inhibition: A randomized Controlled Trial in Posttraumatic Stress Disorder sbullocks@mfa.gwu.edu

Interested in More Information

  • Please enter your first name.
  • Please enter your last name.
  • This isn't a valid email address.
    Please enter your email address.
  • This isn't a valid phone number.
    Please enter your phone number.
    You entered an invalid number.
  • Please enter your address.
  • Please enter your city.
  • Please enter your state.
  • Please enter your zip code.
  • (All Uppercase. No Spaces)